Outsourced Pharma App Notes & Case Studies

41. 4 Ways To Avoid Failure In Phase III Clinical Manufacturing 9/19/2018

    Understanding the challenges in the biopharma space is critical, as the planning you do today dictates the options you have later when the costs — and the stakes — get even higher.

42. Why Invest In Emerging Markets Now 10/10/2018

    Unexplored and emerging markets are an attractive prospect for biopharma companies looking to expand. But when it comes to ensuring success, what’s the wisest way to invest?

43. Best Practices For A Successful Bioprocess Technology Transfer 9/10/2019

    A well-executed bioprocess technology transfer (tech transfer) is critical to ensure smooth knowledge transfer and optimal process reproducibility. 

44. Continuous Chromatography In Downstream Processing Of A mAb 2/1/2018

    In this study, periodic counter current (PCC) chromatography and straight-through processing (STP) technologies were evaluated in a continuous three-step monoclonal antibody (mAb) purification process.

45. How Services Marketers Can Own Their Performance Measures 1/29/2019

    Service marketers can take control of their marketing performance by implementing credible marketing effectiveness measures and creating their own narrative.

46. Purposeful Design And Development Of A Next-Generation Single-Use Bioprocess Film 8/7/2019

    Fortem film development is an important investment by GE Healthcare, as it helps meet the industry need for a fully characterized platform film across all bioprocessing applications with supply chain transparency as a focal point. 

47. Managing Risks To Time Critical Product Imports At Clinical Supply Depots 6/11/2019

    Global regulatory standards for clinical trials are, simply put, complex. In this case study, learn how one company worked with its partner to overcome the challenge of a protocol based in the US, an investigational medical product (IMP) approved in the EU, and varying QP (qualified person) rules from country to country, to conduct their clinical trial in Isreal.

48. The Pharma Trends You Need To Know: A CDMO’s Perspective 10/18/2018

    Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.

49. Partnering With Your Teams To Enhance And Increase Supply Chain Efficiency 4/10/2018

    Emerging biopharmaceutical company teams up with clinical services company to stay on track with timelines and ensure funding milestones were met when faced with unexpected lack of bandwidth and limited global organizational experience.

50. Satisfying Aggressive Timelines With A Simplified Supply Chain For Drug Delivery 1/10/2020

    To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route.